1. Home
  2. PHAR vs ODC Comparison

PHAR vs ODC Comparison

Compare PHAR & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ODC
  • Stock Information
  • Founded
  • PHAR 1988
  • ODC 1941
  • Country
  • PHAR Netherlands
  • ODC United States
  • Employees
  • PHAR N/A
  • ODC N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • PHAR Health Care
  • ODC Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • ODC Nasdaq
  • Market Cap
  • PHAR 731.1M
  • ODC 853.6M
  • IPO Year
  • PHAR N/A
  • ODC N/A
  • Fundamental
  • Price
  • PHAR $10.42
  • ODC $59.51
  • Analyst Decision
  • PHAR Strong Buy
  • ODC
  • Analyst Count
  • PHAR 3
  • ODC 0
  • Target Price
  • PHAR $30.00
  • ODC N/A
  • AVG Volume (30 Days)
  • PHAR 3.5K
  • ODC 84.4K
  • Earning Date
  • PHAR 07-31-2025
  • ODC 06-05-2025
  • Dividend Yield
  • PHAR N/A
  • ODC 1.21%
  • EPS Growth
  • PHAR N/A
  • ODC 17.38
  • EPS
  • PHAR N/A
  • ODC 3.40
  • Revenue
  • PHAR $320,708,000.00
  • ODC $474,062,000.00
  • Revenue This Year
  • PHAR $13.31
  • ODC N/A
  • Revenue Next Year
  • PHAR $7.68
  • ODC N/A
  • P/E Ratio
  • PHAR N/A
  • ODC $17.57
  • Revenue Growth
  • PHAR 24.13
  • ODC 9.92
  • 52 Week Low
  • PHAR $6.65
  • ODC $30.95
  • 52 Week High
  • PHAR $12.61
  • ODC $60.70
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 48.06
  • ODC 61.63
  • Support Level
  • PHAR $9.99
  • ODC $56.71
  • Resistance Level
  • PHAR $10.49
  • ODC $59.76
  • Average True Range (ATR)
  • PHAR 0.33
  • ODC 1.62
  • MACD
  • PHAR -0.11
  • ODC -0.34
  • Stochastic Oscillator
  • PHAR 29.19
  • ODC 73.08

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: